Skip to main content
GTBP
NASDAQ Life Sciences

FDA Clears IND for GTB-5550 in Multiple Myeloma, Expanding TriKE Platform

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$11.29
Mkt Cap
$20.985M
52W Low
$4.91
52W High
$34.25
52W Position info
130% above low
Off High info
67% below high
Rel. Volume info
10× avg
Market data snapshot near publication time

GTBP has more than doubled off its 52-week low of $4.91 on elevated volume (10× avg).

Summary

GT Biopharma received FDA clearance of an IND for GTB-5550 in multiple myeloma, adding a third potential Phase 1 trial to its pipeline. The trial will be investigator-sponsored and initiation is contingent on non-dilutive grant funding. The company also disclosed a proforma cash balance of approximately $11 million as of September 15, 2026, which it expects to fund operations into Q3 2027. This follows the recent 1-for-25 reverse split and a $7.45M private placement, and provides a new clinical catalyst for the stock. The solid tumor Phase 1 trial for GTB-5550 continues enrollment with an update expected in Q4 2026.

At the time of this announcement, GTBP was trading at $11.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21M. The 52-week trading range was $4.91 to $34.25. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

GTBP - Latest Insights

GTBP
Oct 13, 2026, 5:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $6.50
Real-time Price: $5.22 info
Change: -$1.28 (-20%) info
Market Cap: $10.759M info
GTBP
Oct 02, 2026, 5:26 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $5.22 info
Change: -$0.880 (-14%) info
Market Cap: $10.759M info
GTBP
Sep 25, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.89
Real-time Price: $5.22 info
Change: -$1.67 (-24%) info
Market Cap: $10.759M info
GTBP
Sep 21, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.18
Real-time Price: $5.22 info
Change: -$1.96 (-27%) info
Market Cap: $10.759M info
GTBP
Sep 15, 2026, 8:57 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.73
Real-time Price: $5.22 info
Change: -$7.51 (-59%) info
Market Cap: $10.759M info